Free Trial
Daniil Gataulin

Daniil Gataulin Analyst Performance

Sr. Equity Research Analyst at HC Wainwright

Daniil Gataulin is a stock analyst at HC Wainwright focused in the healthcare sector, covering 20 publicly traded companies. Over the past year, Daniil Gataulin has issued 35 stock ratings, including strong buy, buy, and hold recommendations. While full access to Daniil Gataulin's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Daniil Gataulin's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
91 Last 1 Years
Buy Recommendations
91.21% 83 Buy Ratings
Companies Covered
20 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy1.1%1 ratings
Buy90.1%82 ratings
Hold8.8%8 ratings
Sell0.0%0 ratings

Out of 91 total stock ratings issued by Daniil Gataulin at HC Wainwright, the majority (90.1%) have been Buy recommendations, followed by 8.8% Hold and 1.1% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
20 companies

Daniil Gataulin, an analyst at HC Wainwright, currently covers 20 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
19 companies
95.0%
Technology
1 company
5.0%

Daniil Gataulin of HC Wainwright specializes in stock coverage within the Healthcare sector, with additional focus on Technology companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
13 companies
65.0%
PHARMACEUTICALS
6 companies
30.0%
SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT
1 company
5.0%

Daniil Gataulin's Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Energous Corporation stock logo
WATT
Energous
10/27/2026Initiated Coverage$8.44$15.00Buy
CervoMed Inc. stock logo
CRVO
CervoMed
8/3/2026Upgrade$2.81Strong-Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
5/11/2026Upgrade$41.01$61.00Buy
uniQure N.V. stock logo
QURE
uniQure
4/30/2026Boost Price Target$19.95$37.00Buy
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
3/27/2026Reiterated Rating$1.08$4.00Buy
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
3/27/2026Reiterated Rating$7.53$35.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
3/25/2026Reiterated Rating$1.96$7.00Buy
Zura Bio Limited stock logo
ZURA
Zura Bio
3/23/2026Boost Price Target$5.50$11.00Buy
Annexon, Inc. stock logo
ANNX
Annexon
3/20/2026Reiterated Rating$5.49$16.00Buy
CervoMed Inc. stock logo
CRVO
CervoMed
3/18/2026Boost Price Target$4.53$21.00Buy
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
3/12/2026Boost Price Target$5.01$11.00Buy
uniQure N.V. stock logo
QURE
uniQure
3/9/2026Boost Price Target$17.29$31.00Buy
CervoMed Inc. stock logo
CRVO
CervoMed
3/5/2026Reiterated Rating$4.02$15.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
3/5/2026Reiterated Rating$1.96$7.00Buy
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
3/4/2026Boost Price Target$18.00$29.00Buy
uniQure N.V. stock logo
QURE
uniQure
3/3/2026Lower Price Target$10.50$16.00Buy
Oncobiologics, Inc. stock logo
OTLK
Oncobiologics
2/18/2026Reiterated Rating$0.42Neutral
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
2/18/2026Reiterated Rating$6.99$21.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
2/10/2026Lower Price Target$10.31$50.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
1/29/2026Reiterated Rating$11.01$52.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
1/20/2026Reiterated Rating$1.69$7.00Buy
Kalaris Therapeutics Inc. stock logo
KLRS
Kalaris Therapeutics
12/23/2025Initiated Coverage$10.06$19.00Buy
Annexon, Inc. stock logo
ANNX
Annexon
12/23/2025Initiated Coverage$5.19$16.00Buy
Annexon, Inc. stock logo
ANNX
Annexon
12/23/2025Initiated Coverage$5.11$16.00Buy
Kalaris Therapeutics Inc. stock logo
KLRS
Kalaris Therapeutics
12/23/2025Initiated Coverage$9.66$19.00Buy
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
12/9/2025Reiterated Rating$16.11$21.00Buy
uniQure N.V. stock logo
QURE
uniQure
12/4/2025Reiterated Rating$22.21$53.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
11/20/2025Reiterated Rating$10.93$52.00Buy
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
11/17/2025Reiterated Rating$14.08$61.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
11/17/2025Reiterated Rating$19.51$14.00Neutral
Zura Bio Limited stock logo
ZURA
Zura Bio
11/14/2025Reiterated Rating$4.08$10.00Buy
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
11/13/2025Reiterated Rating$1.92$9.00Buy
Oculis Holding AG stock logo
OCS
Oculis
11/11/2025Reiterated Rating$19.42$51.00Buy
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
11/11/2025Reiterated Rating$8.55$35.00Buy
uniQure N.V. stock logo
QURE
uniQure
11/11/2025Reiterated Rating$26.15$53.00Buy
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
11/7/2025Reiterated Rating$1.92$9.00Buy
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
11/5/2025Reiterated Rating$10.90$21.00Buy
uniQure N.V. stock logo
QURE
uniQure
11/3/2025Lower Price Target$34.29$53.00Buy
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
10/27/2025Downgrade$4.24Hold
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
10/16/2025Initiated Coverage$2.00$9.00Buy
Many investors are about to lose everything (Ad)

Twenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a household name. Now he says a similar shift is unfolding in AI infrastructure. Hundreds of billions are pouring into AI data centers, but he warns the builders could get crushed by their own costs while one overlooked sector absorbs the spending.tc pixel

Watch the full Ignition Point broadcast to see his top pick
Oculis Holding AG stock logo
OCS
Oculis
10/8/2025Boost Price Target$19.06$51.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
10/6/2025Reiterated Rating$15.45$14.00Neutral
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
10/2/2025Reiterated Rating$11.04$21.00Buy
Zura Bio Limited stock logo
ZURA
Zura Bio
9/30/2025Reiterated Rating$2.99$10.00Buy
uniQure N.V. stock logo
QURE
uniQure
9/25/2025Boost Price Target$47.50$76.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
9/19/2025Reiterated Rating$1.40$7.00Buy
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
9/15/2025Initiated Coverage$12.81$21.00Buy
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
9/10/2025Downgrade$47.64$48.00Neutral
uniQure N.V. stock logo
QURE
uniQure
9/8/2025Reiterated Rating$17.95$35.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
9/8/2025Reiterated Rating$9.71$52.00Buy
uniQure N.V. stock logo
QURE
uniQure
8/29/2025Reiterated Rating$16.26$35.00Buy
Oncobiologics, Inc. stock logo
OTLK
Oncobiologics
8/28/2025Reiterated Rating$1.09$3.00Neutral
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
8/15/2025Reiterated Rating$10.82$61.00Buy
Zura Bio Limited stock logo
ZURA
Zura Bio
8/15/2025Reiterated Rating$1.72$10.00Buy
Oncobiologics, Inc. stock logo
OTLK
Oncobiologics
8/15/2025Reiterated Rating$2.43$3.00Neutral
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
8/15/2025Reiterated Rating$8.33$35.00Buy
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
8/14/2025Reiterated Rating$21.77$70.00Buy
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
8/13/2025Reiterated Rating$2.58$33.00Buy
CervoMed Inc. stock logo
CRVO
CervoMed
8/11/2025Reiterated Rating$9.85$15.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
8/8/2025Reiterated Rating$7.90$52.00Buy
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
8/8/2025Reiterated Rating$0.68$4.00Buy
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
8/7/2025Reiterated Rating$10.58$27.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
8/4/2025Reiterated Rating$0.99$7.00Buy
uniQure N.V. stock logo
QURE
uniQure
7/29/2025Lower Price Target$13.68$35.00Buy
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
7/18/2025Downgrade$0.60Neutral
Ocugen, Inc. stock logo
OCGN
Ocugen
6/24/2025Reiterated Rating$0.98$7.00Buy
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
6/24/2025Reiterated Rating$12.76$61.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
6/9/2025Reiterated Rating$9.61$52.00Buy
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
5/15/2025Reiterated Rating$1.88$33.00Buy
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
5/14/2025Lower Price Target$5.15$35.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
5/12/2025Reiterated Rating$0.67$7.00Buy
Oculis Holding AG stock logo
OCS
Oculis
5/9/2025Boost Price Target$18.70$33.00Buy
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
5/8/2025Lower Price Target$0.35$4.00Buy
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
5/8/2025Lower Price Target$6.09$27.00Buy
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
4/23/2025Initiated Coverage$17.32$70.00Buy
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
4/17/2025Lower Price Target$2.98$33.00Buy
Oculis Holding AG stock logo
OCS
Oculis
4/17/2025Reiterated Rating$18.02$28.00Buy
uniQure N.V. stock logo
QURE
uniQure
4/1/2025Initiated Coverage$10.60$38.00Buy
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
4/1/2025Lower Price Target$7.43$61.00Buy
Clearside Biomedical, Inc. stock logo
CLSD
Clearside Biomedical
3/28/2025Reiterated Rating$15.45$90.00Buy
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
3/21/2025Lower Price Target$0.43$8.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
3/20/2025Reiterated Rating$8.50$52.00Buy
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
3/14/2025Reiterated Rating$6.55$52.00Buy
Oculis Holding AG stock logo
OCS
Oculis
3/13/2025Reiterated Rating$18.84$28.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
3/6/2025Boost Price Target$0.57$7.00Buy
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
3/6/2025Reiterated Rating$6.82$33.00Buy
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
2/26/2025Reiterated Rating$0.50$11.00Buy
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
2/24/2025Reiterated Rating$7.30$36.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
2/13/2025Reiterated Rating$0.66$6.00Buy
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
2/6/2025Reiterated Rating$7.80$33.00Buy
The warning signs most investors see too late (Ad)

Dr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. Now, after 55 years of market analysis, he says conditions are forming for a financial crisis that could rival or exceed 2008.tc pixel

Watch Dr Weiss's free video warning before conditions worsen further
Ocugen, Inc. stock logo
OCGN
Ocugen
1/23/2025Reiterated Rating$0.75$6.00Buy